Federal prosecutors accuse the Fort Worth cardiologist of participating in an $89 million cardiovascular testing operation that allegedly used false diagnoses, misleading certifications, inaccurate billing information, and interstate electronic communications to obtain reimbursements from government programs and private insurers.
WASHINGTON, DC — Federal charges against Jason Finkelstein place an alleged nationwide cardiovascular testing operation under judicial scrutiny, with prosecutors accusing the Texas cardiologist of joining a conspiracy that converted campus examinations of student athletes into fraudulent reimbursement claims.
The indictment charges Finkelstein with one count of conspiracy to commit healthcare fraud and wire fraud, followed by three substantive healthcare fraud counts involving selected cardiovascular claims that prosecutors identify as executions of the broader alleged billing scheme.
Federal authorities claim the operation submitted more than $89 million in false claims to commercial insurance plans, Medicaid, the Federal Employees Health Benefits Program, and Veterans Health Administration programs between approximately January 2019 and December 2025.
Those healthcare programs allegedly paid more than $13.1 million into accounts associated with Finkelstein’s professional entities, while prosecutors separately claim that he received approximately $1.1 million through checks and electronic transfers funded by insurance reimbursements.
Finkelstein has pleaded not guilty, remains presumed innocent, and possesses the constitutional right to challenge every allegation concerning his medical decisions, electronic approvals, business relationships, financial compensation, corporate responsibilities, and knowledge of disputed insurance submissions.
Four counts define the federal prosecution
The federal indictment filed against Jason Finkelstein identifies Count One as a conspiracy charge alleging an agreement to commit healthcare fraud and wire fraud through materially false representations transmitted across interstate electronic systems.
Counts Two, Three, and Four charge substantive healthcare fraud based upon three particular claim groupings, including two abdominal aorta ultrasound submissions and cardiovascular services associated with a student-athlete who later died following sudden cardiac arrest.
The substantive counts let prosecutors present individual insurance transactions as specific alleged executions, while the conspiracy count lets the government describe a broader agreement involving numerous participants, companies, campus events, certifications, payments, and disputed claims.
A conspiracy conviction does not require prosecutors to prove that every participant personally completed every alleged action, but the government must establish that Finkelstein knowingly and voluntarily joined an unlawful agreement with the required fraudulent purpose.
The three substantive counts require proof connecting Finkelstein with particular executions of the alleged scheme, including material deception affecting a healthcare benefit program and the specific knowledge and intent demanded by federal healthcare fraud law.
Conspiracy allegations reach beyond individual claims
Prosecutors allege that Finkelstein worked with unnamed co-conspirators who operated a cardiovascular testing company based in Boca Raton, Florida, that deployed traveling sonographers to examine student athletes at campuses across the United States.
According to the government, participants promoted the examinations by emphasizing the possibility that apparently healthy athletes could experience sudden cardiac arrest while competing, creating an emotionally powerful reason for students, families, and universities to accept testing.
The indictment alleges that athletic directors and others received checks, electronic transfers, gift cards, or comparable benefits for referring students, although every disputed payment, recipient, purpose, and connection to athlete recruitment remains to be proven.
Once campus access was secured, traveling personnel allegedly performed substantially the same group of six cardiovascular examinations on participating athletes without a physician first conducting the individualized medical evaluation necessary to establish diagnostic need.
The government contends that this standardized testing model generated substantial volume, after which false diagnoses, provider information, service locations, medical certifications, and electronic billing records allegedly transformed preventive screenings into apparently reimbursable diagnostic services.
The wire fraud component concerns electronic transmissions
Wire fraud generally concerns intentional schemes using interstate or foreign electronic communications, meaning prosecutors will examine how disputed claims, supporting documents, insurer responses, payments, messages, and medical certifications moved between states through digital systems.
The indictment alleges that false healthcare claims were submitted through interstate wire communications, linking the alleged billing deception to electronic transmissions that could support the conspiracy charge even if no single participant personally pressed every submission button.
Claims sent through insurer portals, electronic health-record systems, clearinghouses, payment networks, email platforms, or banking channels may generate metadata showing transmission times, user accounts, originating locations, destination systems, attached records, and subsequent payment activity.
Prosecutors must nevertheless establish more than the ordinary use of electronic communications, because wire fraud requires a deceptive scheme and criminal intent rather than simply proving that a medical business transmitted claims, reports, or payments electronically.
Defense lawyers can therefore challenge whether particular communications were misleading, whether Finkelstein knew their contents, whether administrative personnel acted independently, and whether disputed transmissions genuinely advanced an intentional fraud rather than a billing disagreement.
Healthcare fraud focuses upon benefit programs
The healthcare fraud allegations concern programs paying for medical services, including private insurance carriers and government-supported benefits covering federal employees, veterans, and Medicaid beneficiaries whose policies allegedly received claims connected with campus cardiovascular testing.
Federal law does not make every inaccurate medical claim criminal, because prosecutors must prove deliberate deception rather than ordinary coding mistakes, clinical disagreement, incomplete documentation, administrative negligence, or a good-faith misunderstanding of complicated reimbursement requirements.
A delivered medical service can still support a fraud prosecution when authorities allege that the examination was unnecessary, ineligible, falsely diagnosed, improperly represented, insufficiently reviewed, or otherwise presented through materially deceptive information affecting payment.
The government’s case therefore does not depend entirely upon claiming that the cardiovascular examinations never occurred, because prosecutors instead allege that actual testing was packaged and certified through false information that made the services appear reimbursable.
Defense counsel may answer that some athletes had genuine symptoms, family histories, risk factors, or plan-specific eligibility, requiring the government to establish the alleged falsity and criminal intent tied to the charged claims rather than relying on broad patterns.
False diagnoses allegedly supported medical necessity
Prosecutors claim that student athletes received false diagnoses for hypertension, elevated blood pressure, or other conditions they did not possess, allegedly creating documentation that converted broad preventive screening into diagnostic testing eligible for insurance reimbursement.
Medical necessity often depends on individualized facts, including symptoms, physical findings, patient history, existing diagnoses, prior results, physician judgment, and the specific coverage rules set by the applicable benefit plan or insurance contract.
The government will likely compare questionnaires, campus records, clinical histories, claim forms, diagnosis codes, and testimony from participating athletes to determine whether the medical conditions appearing upon reimbursement submissions reflected genuine patient information.
If athletes deny the reported diagnoses, prosecutors may characterize the resulting pattern as deliberate fabrication, while the defense can investigate whether the information came from screening measurements, preliminary observations, coding conventions, or other sources investigators overlooked.
Connecting those diagnoses personally with Finkelstein will remain essential, because inaccurate information entered by marketers, billers, sonographers, contractors, or company employees does not automatically establish that a physician knowingly participated in fraudulent coding.
Provider credentials allegedly supplied medical authority
Finkelstein was a board-certified cardiologist licensed throughout the 48 contiguous states, giving the alleged operation access to medical credentials that could support services involving students tested across numerous jurisdictions and geographically distant college campuses.
Nationwide licensure is lawful and does not, by itself, suggest misconduct, although prosecutors may argue that Finkelstein’s extensive licensing provided essential infrastructure for an operation requiring an authorized ordering, referring, reviewing, or rendering provider in multiple states.
The indictment alleges that it identified Finkelstein as the sole ordering or referring physician even though he had not personally examined participating athletes before testing, evaluated their individual circumstances, or established the necessity of every examination.
Provider identifiers matter because insurers rely upon them to determine who ordered, supervised, interpreted, or delivered services, while also evaluating licensure, enrollment status, contractual eligibility, geographic requirements, and compliance with applicable coverage conditions.
Defense lawyers may contend that Finkelstein operated through lawful protocols, remote review arrangements, standing procedures, delegated clinical functions, or information gathered by others, making the exact meaning of each provider designation an important evidentiary question.
Corporate entities allegedly moved claims and reimbursements
The government says Finkelstein owned Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA, professional associations formed under Texas law and allegedly used to submit claims, receive reimbursements, and appeal insurer denials connected with the examinations.
Corporate ownership may help prosecutors establish authority, access, financial benefit, and knowledge, but ownership alone cannot prove that Finkelstein understood or approved every diagnosis, location code, billing entry, marketing representation, or administrative action attributed to the businesses.
Investigators will likely examine incorporation records, bank statements, contracts, payroll information, insurer enrollment materials, user permissions, internal messages, signature authority, tax records, and payment transfers to reconstruct how the professional associations operated.
Prosecutors allege that additional companies were created to circumvent payer efforts to prevent fraudulent billing and conceal the participation of particular individuals, presenting corporate restructuring as a method of continuing the disputed reimbursement activity.
The defense may argue that newly formed entities served legitimate operational, contracting, liability, licensing, or administrative purposes, requiring the government to prove that concealment and payer circumvention actually motivated the disputed business arrangements.
Place-of-service information allegedly misrepresented locations
Claims sometimes identified Finkelstein’s Tarrant County office as the location where cardiovascular examinations occurred, although prosecutors allege that traveling sonographers actually performed those tests upon college campuses elsewhere in the country.
Place-of-service information can influence payment calculations, provider eligibility, supervision requirements, network rules, and an insurer’s understanding of how treatment occurred, so a knowingly false location may be material to a reimbursement decision.
The government may combine allegedly inaccurate locations with false diagnoses, provider representations, and medical certifications to argue that deceptive information appeared throughout the claims process rather than arising from one isolated clerical mistake.
Defense counsel can investigate whether remote interpretation affected location coding, whether billing software inserted default addresses, whether insurers received corrections, and whether Finkelstein knew how administrative personnel completed fields governing the service location.
A criminal conviction requires proof beyond an inaccurate office address, because mistaken coding, ambiguous payer guidance, software defaults, and negligent administration can generate repayment disputes without necessarily demonstrating an intentional federal fraud scheme.
Medical certifications allegedly completed the billing workflow
Prosecutors claim Finkelstein electronically approved large volumes of cardiovascular results as normal within seconds of opening them, allegedly representing that meaningful physician interpretation occurred when the studies had not received adequate individualized review.
Those certifications could serve two related functions within the government’s theory: providing apparent reassurance to athletes while documenting the professional work insurers expected before paying claims for diagnostic cardiovascular examinations.
The government may present audit logs recording access times, image quantities, user identities, electronic signatures, report changes, login locations, and approval sequences to demonstrate that Finkelstein allegedly certified more material than he could meaningfully evaluate.
The defense can examine whether preliminary reviews occurred outside the recorded platform, whether qualified personnel assessed images beforehand, whether files included duplicates, and whether system timestamps accurately measured the full professional-review process.
Rapid approval may appear suspicious, but speed alone does not establish healthcare fraud, because prosecutors must connect the timing evidence with knowing deception, materially false billing, an unlawful agreement, and Finkelstein’s intent to obtain reimbursements improperly.
Two abdominal ultrasound claims became substantive counts
Counts Two and Three concern abdominal aorta ultrasound claims submitted during 2021, with each identified transaction seeking approximately $150 from commercial insurance plans for services prosecutors allege were medically unnecessary and not provided as represented.
The indictment describes an August 2022 message in which a co-conspirator allegedly asked Finkelstein about abdominal aorta ultrasounds, prompting him to respond that he did not read those examinations and to question why they were performed.
Prosecutors may use that exchange to argue that Finkelstein knew the operation billed examinations he was not interpreting, particularly because the government alleges that abdominal aorta ultrasound claims continued until approximately January 2024.
Defense attorneys may argue that conversational shorthand lacks sufficient context, another professional may have completed the readings, responsibilities may have changed, or the selected exchange may not describe the earlier claims charged as substantive offenses.
The government must authenticate the communications, establish their participants and context, and explain how they demonstrate Finkelstein’s knowledge concerning specific claims rather than merely expressing uncertainty about a separate operational practice.
The fourth count involves a student athlete
Count Four concerns cardiovascular services performed for a student athlete during October 2024, including an electrocardiogram, echocardiogram, and vascular ultrasound examinations collectively billed at approximately $975 to a commercial insurance plan.
The indictment alleges that the athlete’s electronic file contained approximately 63 images, with some carrying preliminary indications of possible right atrial hypertrophy and right ventricular hypertrophy that allegedly warranted meaningful professional consideration.
Prosecutors claim Finkelstein accessed the collection and signed all results as normal about eleven seconds later, characterizing the compressed interval as evidence that he certified the examinations without adequate review.
Approximately 24 days afterward, the athlete died from sudden cardiac arrest while exercising with his basketball team, creating the prosecution’s most emotionally powerful allegation and raising difficult questions involving clinical interpretation, communication, causation, and prejudice.
The athlete’s death does not independently prove healthcare fraud, and the government must still establish that the charged claim contained material deception, that Finkelstein possessed fraudulent intent, and that the alleged certification advanced the scheme.
Medical tragedy and billing intent remain separate
A missed cardiac abnormality could involve negligence, professional disagreement, incomplete information, technical limitations, delegated work, or another medical circumstance without necessarily establishing intentional deception aimed at obtaining insurance reimbursement.
Conversely, prosecutors could establish fraudulent billing without proving that the allegedly false normal designation legally caused the athlete’s death, because healthcare fraud statutes focus upon deception affecting benefit programs rather than medical malpractice causation.
The trial court may therefore need to determine how prosecutors can present evidence surrounding the death without encouraging jurors to decide financial charges through grief, anger, sympathy, or hindsight instead of statutory requirements.
Medical experts may dispute what the images demonstrated, whether the preliminary notation was accurate, what additional review was appropriate, whether intervention was indicated, and whether another interpretation could have prevented the fatal event.
Responsible reporting must preserve this distinction, recognize the profound gravity of a student’s death while avoiding any suggestion that the tragedy has already established Finkelstein’s criminal responsibility or the government’s broader billing theory.
Payments distinguish billing scale from personal compensation
The $89 million figure describes claims allegedly submitted, not the amount insurers paid, the sum Finkelstein personally received, the final restitution calculation, or an existing forfeiture judgment entered against him.
According to the government, approximately $13.1 million was reimbursed through accounts belonging to the professional associations, meaning most of the $89 million claimed amount was denied, reduced, rejected, or otherwise remained unpaid.
Prosecutors separately allege that Finkelstein received approximately $1.1 million from reimbursements through checks and wire transfers issued during the charged period, presenting those payments as evidence that he benefited financially from the operation.
The indictment also seeks an approximately $13.15 million forfeiture money judgment, although that demand remains contingent upon conviction, financial tracing, statutory requirements, judicial findings, and any defenses applicable to the requested property remedy.
Claims submitted, money received, personal compensation, intended loss, actual loss, restitution, and forfeiture represent different legal and accounting concepts, so careful distinctions matter when the prosecution’s financial magnitude is described publicly.
News coverage places the case within a larger crackdown
Associated Press coverage of the federal healthcare fraud takedown identified Finkelstein’s prosecution among hundreds of cases announced through a nationwide enforcement initiative targeting billions of dollars in allegedly fraudulent claims.
The broader operation demonstrates the Justice Department’s increasing use of claims analytics, electronic records, financial tracing, interagency investigations, and concentrated prosecution teams to identify providers whose billing patterns differ sharply from expected medical practice.
However, a national announcement does not lessen the government’s burden in Finkelstein’s individual case, because public enforcement priorities, aggregate dollar figures, and accusations against unrelated defendants cannot substitute for admissible evidence proving his charges.
The defense may seek to prevent jurors from associating Finkelstein with other takedown defendants whose alleged activities involve different services, beneficiaries, financial losses, kickbacks, identities, corporate arrangements, or evidence of personal spending.
Each count must ultimately be evaluated through evidence particular to this prosecution, notwithstanding the government’s decision to announce the case alongside a sweeping healthcare fraud initiative designed to demonstrate national enforcement intensity.
Electronic evidence may shape both sides’ arguments
Claims databases can reveal repeated test combinations, diagnosis patterns, service locations, reimbursement rates, physician identifiers, denial appeals, and approval timelines across thousands of transactions, enabling prosecutors to describe an alleged systematic operation.
Electronic medical platforms may separately record when files were uploaded, opened, altered, certified, downloaded, or transmitted, potentially allowing investigators to compare represented physician work with the time reflected by system activity.
Financial records can connect reimbursements with corporate accounts, participant payments, referral transfers, professional compensation, and newly created entities, while communications may reveal how participants understood insurer resistance and internal review practices.
Digital records are not automatically self-explanatory, because their meaning depends upon system design, user permissions, authentication, clock accuracy, workflow conventions, shared access, data exports, and activities occurring beyond the platform.
Both sides will likely require technical witnesses who can explain what the metadata proves, what it cannot establish, and whether investigators interpreted electronic events consistently with the systems’ actual operation.
The government must prove knowledge and intent
Prosecutors may combine corporate ownership, medical-director responsibilities, nationwide licensing, approval timestamps, payment records, internal messages, disputed diagnoses, service locations, and post-denial appeals to argue that Finkelstein knowingly joined the alleged conspiracy.
Circumstantial evidence can establish intent because defendants rarely document a fraudulent purpose explicitly, although jurors must distinguish reasonable inferences from speculation and determine whether innocent explanations create a reasonable doubt.
The defense may argue that marketers-controlled recruitment, sonographers performed examinations, billers entered diagnoses, administrators submitted claims, outside entities communicated with campuses, and other individuals managed the details now attributed collectively to Finkelstein.
Finkelstein’s lawyers can also contend that clinical disagreements, imperfect oversight, rapid workflow, corporate complexity, or administrative errors do not establish that he deliberately agreed to defraud healthcare programs through interstate communications.
The decisive issue will be whether the evidence proves knowing and willful participation beyond a reasonable doubt, not merely whether Finkelstein held an important position within the businesses where the disputed claims originated.
Presumption of innocence governs every count
An indictment records accusations authorized for prosecution by a grand jury, but it does not reflect a trial verdict, resolve contested medical evidence, establish financial calculations, or eliminate the government’s constitutional burden.
Finkelstein may challenge the credibility of cooperating witnesses, the completeness of digital records, the interpretation of communications, the accuracy of insurer testimony, and the methodology used to classify testing as unnecessary or fraudulent.
Expert witnesses may disagree about cardiovascular screening standards, physician review practices, coding requirements, remote interpretation, medical necessity, software workflows, and whether the government has applied payer rules consistently across the charged period.
Jurors must consider each count separately, meaning evidence supporting the conspiracy allegation does not automatically prove every substantive healthcare fraud transaction, while an acquittal or conviction upon one count does not mechanically determine another.
Any discussion of punishment remains premature because potential consequences would depend upon the counts resolved, attributed loss, sentencing guidelines, criminal history, judicial findings, restitution, forfeiture, statutory limits, and individualized mitigating or aggravating circumstances.
Lawful mobility cannot erase pending federal obligations
The prosecution illustrates the principle examined in Amicus International’s analysis of lawful identity-change myths, because a legal change involving citizenship, residence, name, or documentation cannot cancel an indictment, court order, financial claim, or duty to appear.
Amicus International’s overview of United States extradition procedures similarly explains that international surrender follows established legal processes, meaning foreign residence or additional citizenship cannot lawfully defeat prosecution, judicial supervision, restitution, or forfeiture proceedings.
Nothing within the public allegations examined for this article suggests that Finkelstein attempted to flee, conceal his location, violate release conditions, or avoid court, making these broader principles explanatory rather than assertions of additional wrongdoing.
Any federal defendant released before trial must comply with applicable travel, employment, reporting, contact, document-surrender, and appearance requirements, while seeking judicial approval before undertaking conduct potentially inconsistent with the controlling release order.
Lawful international planning remains available to eligible people, but it cannot be used to obstruct justice, hide forfeitable assets, frustrate lawful process, mislead authorities, or escape obligations created by a pending criminal proceeding.
The case moves toward an April 2027 trial
Current Justice Department information schedules a September 16, 2026 status conference, a March 30, 2027 calendar call, and an April 5, 2027 trial before United States District Judge Aileen Cannon in West Palm Beach.
That timetable gives both sides months to review medical images, billing histories, insurer policies, campus records, athlete questionnaires, referral payments, electronic audit logs, corporate documents, financial transfers, and communications spanning several years.
Pretrial litigation may address discovery volume, medical privacy, expert reliability, electronic authentication, co-conspirator statements, hearsay, disputed clinical standards, financial evidence, and the admissibility of circumstances surrounding the student-athlete’s death.
The court may also evaluate whether particular statements, transactions, or claim examples properly demonstrate the broader conspiracy, while guarding against unfair prejudice arising from unrelated conduct or emotionally charged evidence.
Until those disputes are resolved and the evidence is tested in adversarial proceedings, every allegation concerning false diagnoses, unnecessary testing, rapid certifications, misleading claims, referral payments, concealment, and financial benefit remains unproved.
A prosecution centered upon trust and certification
The federal case ultimately asks whether Finkelstein’s medical credentials and electronic certifications reflected genuine professional judgment or provided the apparent legitimacy needed to turn standardized campus screenings into reimbursable diagnostic services.
For prosecutors, the conspiracy count connects recruitment, testing, diagnosis creation, physician approval, interstate claims, insurer payments, corporate entities, and participant compensation into one coordinated operation allegedly designed to obtain money through deception.
For the defense, those functions may reflect separate decisions made by marketers, sonographers, billers, administrators, contractors, and business associates whose conduct cannot establish Finkelstein’s criminal intent merely because his name appeared within the workflow.
Government programs and private insurers will focus upon whether truthful information supported payment, while universities and families will examine whether the testing arrangement delivered careful medical evaluation consistent with its potentially lifesaving presentation.
Until a jury returns a verdict or another lawful resolution concludes the prosecution, Jason Finkelstein remains presumed innocent, and the healthcare fraud and wire fraud conspiracy accusations remain serious federal allegations rather than established findings.
